Recall Register

Food, drugs, devices › Biosense Webster, Inc.

Device recall: CARTO 3 EP Navigation System and Accessories, Product Codes: FG540000 and FG540000C, Software Versions: v 3.2 , v 4.3 an

FDA enforcement event 75012 · Class II · initiated 15 Aug 2016 · status Terminated · terminated 20 Jan 2017

DeviceVoluntary: Firm initiated1 product recordIrwindale, CA

Biosense Webster, Inc. (Irwindale, CA) initiated this device recall on 15 Aug 2016; FDA lists 1 product record under event 75012, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 20 Jan 2017. Initiation: voluntary: firm initiated. Biosense Webster, Inc. has 21 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Biosense Webster, Inc., Irwindale, CA.

Reason for recall

"Biosense Webster, Inc. is initiating a voluntary correction to re-install identified CARTO 3 Systems that were moved and installed in China without testing and approval by Biosense Webster Technical Services, as described in the Instructions for Use (IFU)."

Distribution

"International Distribution to China, Hong Kong and Brazil."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2776-2016CARTO 3 EP Navigation System and Accessories, Product Codes: FG540000 and FG540000C, Software Versions: v 3.2 , v 4.3 and v 2.3. The CARTO 3 EP Navigation System is intended to be used in catheter-based cardiac electrophysiological (EP) procedures. The CARTO 3 System provides information about the electrical activity…338 unitsClass IITerminated21 Sep 2016

Context

91%of 2016 device events are Class II1,232 events that year
1product record in this eventfirm median: 1
21events on this register for the firm

Other enforcement events for Biosense Webster, Inc.

InitiatedProduct (first record)TypeClassRecords
5 Jan 2025VARIPULSE Bi-Directional Ablation Catheter REF D141201. The Field Catheter is indicated for use in catheter based cardiaDeviceClass I1
16 Feb 2024CARTO VIZIGO Bi-Directional Guiding Sheath, REF D128502 The CARTO VIZIGOTM Bi-Directional Guiding Sheath is designed to DeviceClass II1
21 Feb 2023Biosense Webster Carto Vizigo Bi-Directional Guiding Sheath, 8.5F(Small), REF D-1385-01-S, RX CE 2797, SterileDeviceClass II2
29 Jun 2022CARTO VIZIGO 8.5F Bi-Directional Guiding Sheath, REF: D138501. Used to introduce various cardiovascular catheters into tDeviceClass II1
26 Feb 2021Biosense Webster, CARTO VIZIGO, Bi-Directional Guiding Sheath, 8.5F (SMALL) C3, REF: D138501, Rx Only, CE 2797, STERILE DeviceClass II3
7 May 2018WaveCrest Left Atrial Appendage (LAA), Occlusion System (32 mm), Catalog Numbers WCR1523 and WCR2523.DeviceClass I1
6 Sep 2017THERMOCOOL SMARTTOUCH SF Uni-Directional Product Codes D-1347-01-S, D-1347-02-S, D-1347-03-SDeviceClass II5
14 Jun 2017SMARTABLATE RF System GeneratorDeviceClass II1
17 May 2017PENTARAY NAV High-Density Mapping Catheter.DeviceClass II2
14 Apr 2016Pentaray NAV High-Density Mapping Catheter, Catalog No. D128201, D128202, D128203, D128204, D128205, D128206 The BiosensDeviceClass II2

All 21 events for Biosense Webster, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Biosense Webster, Inc. is initiating a voluntary correction to re-install identified CARTO 3 Systems that were moved and installed in China without testing and approval by Biosense Webster Technical Services, as described in the Instructions for Use (IFU)."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "International Distribution to China, Hong Kong and Brazil."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 20 Jan 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.